Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

News

What did Berkshire buy in Q3?

Greggory Warren, CFA  |  20 Nov 2020Text size  Decrease  Increase  |  
Email to Friend

Unlike most periods, there were a few surprises in wide-moat Berkshire Hathaway's third-quarter 13-F filing. 

The firm took positions in four different healthcare firms - AbbVie, Merck, Bristol-Myers Squibb, and Pfizer - while making meaningful reductions in several of its bank holdings - JPMorgan Chase, PNC Financial Services, Wells Fargo, and M&T Bank.

The Securities and Exchange Commission's Form 13F is a quarterly report that is required to be filed by all institutional investment managers with at least $100 million in assets under management disclosing their equity holdings.

We had some sense about the Wells Fargo trades, noting that Berkshire (through information provided in its Form 4 and Schedule 13G filings intra-quarter) seemed to be swapping out of Wells Fargo in favor of Bank of America (where the insurer now holds more than 1 billion shares following the purchase of an additional 85 million shares during the third quarter).

While Bank of America accounted for 10.6 per cent of Berkshire's $228.9 billion 13-F portfolio at the end of September 2020, Apple (despite the sale of some 36 million share post the company's 4-for-1 split) remained its largest holding, accounting for 47.8 per cent of the portfolio's holdings (up from 44.1 per cent at the end of June 2020).

Other sales during the September quarter included a 40 per cent reduction in the insurer's stake in Barrick Gold, and mid-single-digit declines in holdings in Liberty Global, DaVita, and Axalta.

Proceeds from these sales helped fund the new-money purchases of the aforementioned healthcare names, as well as a new-money purchase of T-Mobile US and participation in the Snowflake initial public offering.

Other positions that Berkshire added to during the quarter included Kroger, Liberty Latin America, and General Motors.

As holdings in foreign investments that are held abroad, such as Berkshire's $5 billion stake in BYD Corporation, are not disclosed in the company's 13-F filing, it did not pick up the 5 per cent stakes that the insurer took in each of five leading Japanese trading companies--Itochu, Marubeni, Mitsubishi, Mitsui, and Sumitomo - which were worth around $6 billion on a combined basis at the end of last month.

Greggory Warren, CFA, is a senior stock analyst with Morningstar.

Any Morningstar ratings/recommendations contained in this report are based on the full research report available from Morningstar.

© 2020 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written consent of Morningstar. Any general advice or 'class service' have been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/s/fsg.pdf. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782. The article is current as at date of publication.

Email To Friend